ITEM 2: |
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
|
Unless indicated otherwise, or the context otherwise requires, references in this report to the “Company,” “Morgan Group,” “Morgan,” “we,”
“us,” and “our” or similar terms are to Morgan Group Holding Co. and its subsidiary.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
Our disclosure and analysis in this Form 10-Q contains some forward-looking statements. Forward-looking statements give our current expectations or forecasts of future events. You can identify these statements
because they do not relate strictly to historical or current facts. They use words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will,” “should,” “may,” and other words and terms of similar meaning. They
also appear in any discussion of future operating or financial performance. In particular, these include statements relating to future actions, future performance of our products, expenses, the outcome of any legal proceedings, and financial
results. Although we believe that we are basing our expectations and beliefs on reasonable assumptions within the bounds of what we currently know about our business and operations, there can be no assurance that our actual results will not
differ materially from what we expect or believe. We are providing these statements as permitted by the Private Litigation Reform Act of 1995. We do not undertake to update publicly any forward-looking statements if we subsequently learn that we
are unlikely to achieve our expectations or if we receive any additional information relating to the subject matters of our forward-looking statements.
OVERVIEW
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the
notes thereto included in Part I, Item 1 of this Form 10-Q. This discussion contains forward-looking statements and involves numerous risks and uncertainties. Our actual results could differ materially from those
anticipated by such forward-looking statements as discussed under “Cautionary Statement Regarding Forward-Looking Statements” appearing elsewhere in this Form 10-Q.
Morgan Group (OTC Pink®: MGHL), through G.research, acts as an underwriter and provides institutional research services. Institutional research services revenues consist of brokerage
commissions derived from securities transactions executed on an agency basis or direct payments from institutional clients as well as underwriting profits, selling concessions and management fees associated with underwriting activities.
Commission revenues vary directly with the perceived value of the research provided, as well as account activity and new account generation.
RESULTS OF OPERATIONS
The following table (in thousands, except per share data) and discussion of our results of operations are based upon data derived from the Condensed Consolidated Statements of Operations contained in our condensed
consolidated financial statements and should be read in conjunction with those statements included in Part I, Item 1 of this Form 10-Q:
|
|
Three months ended September 30,
|
|
|
Nine months ended September 30,
|
|
|
|
2023
|
|
|
2022
|
|
|
2023
|
|
|
2022
|
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
Commissions
|
|
$
|
462
|
|
|
$
|
390
|
|
|
$
|
1,366
|
|
|
$
|
1,343
|
|
Principal transactions
|
|
|
(0
|
)
|
|
|
0
|
|
|
|
(2
|
)
|
|
|
8
|
|
Dividends and interest
|
|
|
24
|
|
|
|
16
|
|
|
|
87
|
|
|
|
30
|
|
Other revenues
|
|
|
1
|
|
|
|
7 |
|
|
|
2
|
|
|
|
17
|
|
Total revenues
|
|
|
487
|
|
|
|
413
|
|
|
|
1,453
|
|
|
|
1,397
|
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Compensation and related costs
|
|
|
294
|
|
|
|
275
|
|
|
|
884
|
|
|
|
895
|
|
Clearing charges
|
|
|
188
|
|
|
|
116
|
|
|
|
613
|
|
|
|
574
|
|
General and administrative
|
|
|
199
|
|
|
|
191
|
|
|
|
732
|
|
|
|
653
|
|
Occupancy and equipment
|
|
|
38
|
|
|
|
20
|
|
|
|
112
|
|
|
|
162
|
|
Total expenses
|
|
|
719
|
|
|
|
602
|
|
|
|
2,341
|
|
|
|
2,284
|
|
Loss before income tax benefit
|
|
|
(232
|
)
|
|
|
(189
|
)
|
|
|
(888
|
)
|
|
|
(887
|
)
|
Income tax benefit
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Net loss
|
|
$
|
(232
|
)
|
|
$
|
(189
|
)
|
|
$
|
(888
|
)
|
|
$
|
(887
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted
|
|
$
|
(0.39
|
)
|
|
$
|
(0.31
|
)
|
|
$
|
(1.48
|
)
|
|
$
|
(1.48
|
)
|
Three Months Ended September 30, 2023 as Compared to the Three Months Ended September 30, 2022
Revenues
Institutional research services revenues by revenue component, excluding principal transactions and dividends and interest, were as follows (dollars in thousands):
|
|
Three Months Ended September 30,
|
|
|
Increase (Decrease)
|
|
|
|
2023
|
|
|
2022
|
|
|
$
|
|
|
%
|
|
Commissions
|
|
$
|
450
|
|
|
$
|
369
|
|
|
$
|
81
|
|
|
|
21.9
|
%
|
Hard dollar payments
|
|
|
12
|
|
|
|
21
|
|
|
|
(8
|
)
|
|
|
-40.9
|
%
|
Total
|
|
$
|
462
|
|
|
$
|
390
|
|
|
$
|
73
|
|
|
|
18.6
|
%
|
Commissions and hard dollar payments for the three months ended September 30, 2023 were $0.5 million, a $0.1 million, or 18.6%, increase from $0.4 million in the comparable 2022 period. The
increase was primarily due to higher brokerage commissions from securities transactions executed on an agency basis. For the three months ended September 30, 2023 and 2022, respectively, G.research earned $0.3 million and $0.2 million, or
approximately 70% and 64%, of its commission revenue from transactions executed on behalf of funds advised by Gabelli Funds, LLC (“Gabelli Funds”) and clients advised by GAMCO Asset Management Inc. (“GAMCO Asset”).
Principal Transactions
During the three months ended September 30, 2023 revenues (loss) from principal transactions were negligible.
Expenses
Total expenses were $0.7 million for the three months ended September 30, 2023, an increase of $0.1 million, or 19.4%, from $0.6 million in the comparable 2022 period. The increase results primarily
from higher clearing and general and administrative expenses increases.
Compensation costs, which includes salaries, bonuses, and benefits, were $0.3 million for the three months ended September 30, 2023, consistent with the $0.3 million for the three months ended
September 30, 2022.
Income Tax Benefit
The effective tax rate (“ETR”) for the three months ended September 30, 2023 and 2022 was 0.0% and 0.0%, respectively, and the ETR for the nine months ended September 30, 2023 and 2022 was 0.0% and 0.0%,
respectively. The ETR differs from the U.S. corporate rate of 21% due to the change in the deferred income taxes offset by an increase in the federal and state valuation allowances.
Net Loss
Net loss for the three months ended September 30, 2023 and September 30, 2022 was $0.2 million.
Nine Months Ended September 30, 2023 as Compared to the Nine Months Ended September 30, 2022
Revenues
Institutional research services revenues by revenue component, excluding principal transactions and dividends and interest, were as follows (dollars in thousands):
|
|
Nine Months Ended September 30,
|
|
|
Increase (Decrease)
|
|
|
|
2023
|
|
|
2022
|
|
|
$ |
|
|
%
|
|
Commissions
|
|
$
|
1,301
|
|
|
$
|
1,250
|
|
|
$
|
51
|
|
|
|
4.1
|
%
|
Hard dollar payments
|
|
|
65
|
|
|
|
94
|
|
|
|
(28
|
)
|
|
|
-30.1
|
%
|
Total
|
|
$
|
1,366
|
|
|
$
|
1,343
|
|
|
$
|
23
|
|
|
|
1.7
|
%
|
Commissions and hard dollar payments in the 2023 period were $1.4 million, a $0.1 million, or 1.7%, increase from $1.3 million in the comparable 2022 period. The increase was primarily due to
higher brokerage commissions from securities transactions executed on an agency basis. For the nine months ended September 30, 2023, respectively, G.research earned $0.9 million and $0.8 million, or approximately 68% and 58%, of its commission
revenue from transactions executed on behalf of funds advised by Gabelli Funds and clients advised by GAMCO Asset.
Principal Transactions
During the nine months ended September 30, 2023 and 2022, net gains (losses) from principal transactions were negligible.
Interest and dividend income increased by $0.057 to $0.087 million over the nine months ended September 30, 2023 from $0.03 million over the comparable 2022 period due to increasing short-term
interest rates.
Expenses
Total expenses were $2.3 million for the nine months ended September 30, 2023 and September 30, 2022.
Compensation costs, which includes salaries, bonuses, and benefits, were $0.9 million for the nine months ended September 30, 2023 and the nine months ended September 30, 2022.
Clearing expenses were flat at $0.6 million for the nine months ended September 30, 2023 over the same period in 2022.
Income Tax Benefit
For the nine months ended September 30, 2023 and 2022, we recorded income tax benefits of $0.0 million and $0.0 million, respectively, and the ETR was 0.0% and 0.0%, respectively. The ETR differs from the U.S. corporate rate of 21% due to the change in the deferred income taxes offset by an increase in the federal and state valuation allowances.
Net Loss
Net loss was $0.9 million for the nine months ended September 30, 2023 and September 30, 2022.
LIQUIDITY AND CAPITAL RESOURCES
Our principal assets are highly liquid in nature and consist of cash and cash equivalents, comprised primarily of a 100% U.S. Treasury money market fund, The Gabelli U.S. Treasury
Money Market Fund, advised by Gabelli Funds, LLC, which is an affiliate of the Company. Summary cash flow data for the first nine months of 2023 and 2022 was as follows (in thousands):
|
|
Nine months ended September 30,
|
|
|
|
2023
|
|
|
2022
|
|
Cash flows provided by (used in) activities:
|
|
|
|
|
|
|
Operating activities
|
|
$
|
(996
|
)
|
|
$
|
(504
|
)
|
Financing activities
|
|
|
-
|
|
|
|
-
|
|
Net decrease in cash and cash equivalents
|
|
|
(996
|
)
|
|
|
(504
|
)
|
Cash and cash equivalents, beginning of period
|
|
|
2,286
|
|
|
|
2,889
|
|
Cash and cash equivalents, end of period
|
|
$
|
1,290
|
|
|
$
|
2,385
|
|
As of September 30, 2023 the Company had cash and cash equivalents of $1.3 million. Net cash used by operating activities was $1.0 million for the nine months ended September 30, 2023, resulting from a net loss of
$0.9 million. As of September 30, 2022 the Company had cash and cash equivalents of $2.4 million. Net cash used by operating activities was $0.5 million for the nine months ended September 30, 2022, resulting from a net loss of $0.9 million, a
net increase in operating liabilities of $0.1 million and a decrease in operating assets of $0.3 million.
Critical Accounting Policies
The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make
estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the condensed consolidated financial statements and the reported amounts of revenues and
expenses during the reporting periods presented. Actual results could differ significantly from those estimates. See Note B in Part II, Item 8, Financial Statements and Supplementary Data, and the
Company’s Critical Accounting Policies in Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in Morgan Group’s 2022 annual report on Form 10-K filed
with the SEC on March 31, 2023 for details on Critical Accounting Policies.
ITEM 3. |
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
Smaller reporting companies are not required to provide the information required by this item.
ITEM 4. |
CONTROLS AND PROCEDURES
|
The Company maintains a system of disclosure controls and procedures that is designed to provide reasonable assurance that information, which is required to be timely disclosed, is recorded,
processed, summarized, and reported to management within the time periods specified in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. The Company’s principal executive officer and principal financial officer, after evaluating the
effectiveness of the Company’s disclosure controls and procedures (as defined in the Exchange Act) as of the end of the period covered by this report, have concluded that the Company’s disclosure controls and procedures are effective to provide
reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the Company’s management, including its principal executive officer
and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure and are effective to provide reasonable assurance that such information is recorded, processed, summarized and reported within the time
periods specified in the SEC’s rules and forms.
There have been no changes in our internal control over financial reporting, as defined by Rule 13a-15(f) that occurred during our most recently completed fiscal quarter that have materially affected, or are
reasonably likely to materially affect, our internal control over financial reporting.
PART II: OTHER INFORMATION
ITEM 1. |
LEGAL PROCEEDINGS
|
From time to time, the Company may be named in legal actions and proceedings. These actions may seek substantial or indeterminate compensatory as well as punitive damages or injunctive relief. The Company is also
subject to governmental or regulatory examinations or investigations. The examinations or investigations could result in adverse judgments, settlements, fines, injunctions, restitutions or other relief. For any such matters, the condensed
consolidated financial statements include the necessary provisions for losses that the Company believes are probable and estimable. Furthermore, the Company evaluates whether there exist losses which may be reasonably possible and will, if
material, make the necessary disclosures. However, management believes such amounts, both those that are probable and those that are reasonably possible, are not material to the Company’s financial condition, results of operations, or cash flows
at September 30, 2023. See also Note 9, Guarantees, Contingencies, and Commitments, to the condensed consolidated financial statements in Part I, Item I of this Form 10-Q.
Smaller reporting companies are not required to provide the information required by this item.
|
|
Certification of CEO pursuant to Rule 13a-14(a).
|
|
|
|
|
|
Certification of CAO pursuant to Rule 13a-14(a).
|
|
|
|
|
|
Certification of CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Certification of CAO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.
|
|
|
|
101.INS
|
XBRL Instance Document
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
MORGAN GROUP HOLDING CO.
(Registrant)
By: /s/ Joseph L. Fernandez
Name: Joseph L. Fernandez
Title: Executive Vice President - Finance
Date: November 20, 2023
20